SALMON EVOLUTION ASA (SALME.OL) Stock Fundamental Analysis
Europe - OSL:SALME - NO0010892094 - Common Stock
5.18 NOK
+0.05 (+0.97%)
Overall SALME gets a fundamental rating of 2 out of 10. We evaluated SALME against 57 industry peers in the Food Products industry. SALME may be in some trouble as it scores bad on both profitability and health. SALME is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SALME had negative earnings in the past year.
SALME had a negative operating cash flow in the past year.
SALME had negative earnings in each of the past 5 years.
SALME had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
SALME's Return On Assets of -5.15% is on the low side compared to the rest of the industry. SALME is outperformed by 80.70% of its industry peers.
SALME's Return On Equity of -8.41% is on the low side compared to the rest of the industry. SALME is outperformed by 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.15% | ||
| ROE | -8.41% | ||
| ROIC | N/A |
ROA(3y)-2.76%
ROA(5y)-2.34%
ROE(3y)-3.94%
ROE(5y)-3.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SALME's Gross Margin of 62.88% is amongst the best of the industry. SALME outperforms 92.98% of its industry peers.
In the last couple of years the Gross Margin of SALME has declined.
The Profit Margin and Operating Margin are not available for SALME so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SALME does not have a ROIC to compare to the WACC, probably because it is not profitable.
SALME has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SALME has more shares outstanding
The debt/assets ratio for SALME has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.92, we must say that SALME is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SALME (0.92) is worse than 80.70% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that SALME is not too dependend on debt financing.
SALME's Debt to Equity ratio of 0.41 is fine compared to the rest of the industry. SALME outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.92 |
ROIC/WACCN/A
WACC7.87%
2.3 Liquidity
SALME has a Current Ratio of 0.96. This is a bad value and indicates that SALME is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.96, SALME is doing worse than 71.93% of the companies in the same industry.
SALME has a Quick Ratio of 0.96. This is a bad value and indicates that SALME is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.53, SALME is doing worse than 73.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
SALME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.00%.
SALME shows a decrease in Revenue. In the last year, the revenue decreased by -6.20%.
Measured over the past years, SALME shows a very strong growth in Revenue. The Revenue has been growing by 238.62% on average per year.
EPS 1Y (TTM)-95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1700%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y238.62%
Revenue growth 5YN/A
Sales Q2Q%-46.54%
3.2 Future
SALME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.13% yearly.
The Revenue is expected to grow by 51.35% on average over the next years. This is a very strong growth
EPS Next Y-278.29%
EPS Next 2Y32.3%
EPS Next 3Y64%
EPS Next 5Y81.13%
Revenue Next Year-16.12%
Revenue Next 2Y17.79%
Revenue Next 3Y44.05%
Revenue Next 5Y51.36%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
SALME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SALME. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SALME's earnings are expected to grow with 64.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.3%
EPS Next 3Y64%
5. Dividend
5.1 Amount
SALME does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:SALME (11/10/2025, 7:00:00 PM)
5.18
+0.05 (+0.97%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners21.03%
Inst Owner ChangeN/A
Ins Owners2.19%
Ins Owner ChangeN/A
Market Cap2.40B
Revenue(TTM)341.04M
Net Income(TTM)-176.66M
Analysts85.33
Price Target8.43 (62.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-215.55%
Min EPS beat(2)-220.42%
Max EPS beat(2)-210.68%
EPS beat(4)1
Avg EPS beat(4)-422.53%
Min EPS beat(4)-1265.05%
Max EPS beat(4)6.04%
EPS beat(8)2
Avg EPS beat(8)-223.01%
EPS beat(12)5
Avg EPS beat(12)-150.61%
EPS beat(16)9
Avg EPS beat(16)-104.98%
Revenue beat(2)0
Avg Revenue beat(2)-30.39%
Min Revenue beat(2)-43.93%
Max Revenue beat(2)-16.84%
Revenue beat(4)1
Avg Revenue beat(4)-23.17%
Min Revenue beat(4)-43.93%
Max Revenue beat(4)1.98%
Revenue beat(8)3
Avg Revenue beat(8)-20.9%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-120%
EPS NY rev (1m)-14.34%
EPS NY rev (3m)-4140%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-28.73%
Revenue NY rev (1m)-5.24%
Revenue NY rev (3m)-20.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 7.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.14 | ||
| P/tB | 1.19 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.74
BVpS4.54
TBVpS4.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.15% | ||
| ROE | -8.41% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.88% | ||
| FCFM | N/A |
ROA(3y)-2.76%
ROA(5y)-2.34%
ROE(3y)-3.94%
ROE(5y)-3.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.83%
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 988.05% | ||
| Cap/Sales | 235.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 0.92 |
F-Score2
WACC7.87%
ROIC/WACCN/A
Cap/Depr(3y)4495.02%
Cap/Depr(5y)15899.7%
Cap/Sales(3y)642.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1700%
EPS Next Y-278.29%
EPS Next 2Y32.3%
EPS Next 3Y64%
EPS Next 5Y81.13%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y238.62%
Revenue growth 5YN/A
Sales Q2Q%-46.54%
Revenue Next Year-16.12%
Revenue Next 2Y17.79%
Revenue Next 3Y44.05%
Revenue Next 5Y51.36%
EBIT growth 1Y-161.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-27184.6%
EBIT Next 3Y1473.03%
EBIT Next 5Y573.03%
FCF growth 1Y-44.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.05%
OCF growth 3YN/A
OCF growth 5YN/A
SALMON EVOLUTION ASA / SALME.OL FAQ
What is the fundamental rating for SALME stock?
ChartMill assigns a fundamental rating of 2 / 10 to SALME.OL.
Can you provide the valuation status for SALMON EVOLUTION ASA?
ChartMill assigns a valuation rating of 1 / 10 to SALMON EVOLUTION ASA (SALME.OL). This can be considered as Overvalued.
Can you provide the profitability details for SALMON EVOLUTION ASA?
SALMON EVOLUTION ASA (SALME.OL) has a profitability rating of 1 / 10.